News
The FDA has lifted its hold on Elevidys for ambulatory patients, after asking Sarepta to pause the treatment following three deaths.
Brown University took out another private loan, securing a $500 million agreement after the Ivy League school warned of “deep ...
Detailed price information for Arrowhead Pharma (ARWR-Q) from The Globe and Mail including charting and trades.
The Revell family hoped a gene therapy could buy time for their sons, who have a rare and fatal disease. After two patients ...
6d
Clinical Trials Arena on MSNSarepta refuses to pull gene therapy despite FDA requestSarepta Therapeutics is refusing to pull its gene therapy Elevidys (delandistrogene moxeparvovec), despite a request from the FDA.
Sarepta Therapeutics is pausing shipments of its gene therapy for muscular dystrophy following several patient deaths that ...
Sarepta Therapeutics announces voluntary pause all shipments of Elevidys for Duchenne muscular dystrophy in US: Cambridge, Massachusetts Wednesday, July 23, 2025, 12:00 Hrs [IST] ...
Most Americans encounter the Federal Trade Commission only if they’ve been scammed: It handles identity theft, fraud, and ...
Welcome to our live blog tracking the latest news and developments from the United States. Stay updated with real-time ...
Medicaid and ACA, the homeless crisis, children's health, 'black box' drug warnings, nutrition and SNAP, maternity care, and more.
The Motley Fool. DATE Tuesday, July 22, 2025 at 8:00 a.m. ET Read More: Earn up to $845 cash back this year just by changing how you pay at Costco! Learn more here. CALL PARTICIPANTS President and ...
Sarepta Therapeutics shares surged more than 30% before the bell on Tuesday, as analysts said the resumption of U.S. shipments for its muscular gene therapy partially removes financial headwinds and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results